Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × CPX-351 × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 8 Magnetic Resonance Spectroscopy 6 Biopsy 5 Radiotherapy 4 Cytarabine 4 Cyclophosphamide 4 Standard of Care 3 Practice Guidelines as Topic 3 venetoclax 2 merphos 2 X-Rays 2 Vincristine 2 Spinal Puncture 2 Radiation 2 Methotrexate 2 Hydrocortisone 2 Dexamethasone 2 Daunorubicin 2 Calcium Dobesilate 2 Bortezomib 2 Azacitidine 2 zanubrutinib 1 sulforaphane 1 sacituzumab govitecan 1 revumenib 1 prednylidene 1 pembrolizumab 1 pegaspargase 1 nelarabine 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05628623 2024-07-03

ERASE

Eastern Cooperative Oncology Group

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡